Michael A. Metzger, President and COO at Syndax Pharmaceuticals Inc (SNDX), sold 15,000 shares at $20.19 ($303K) on 2021-02-01, disclosed to the SEC on 2021-02-03.
Open-market sale of $303k SNDX by President and COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SNDX | SELL | 2026-02-10 | $361K | — | Filing → |
| SNDX | SELL | 2026-02-06 | $153K | — | Filing → |
| SNDX | SELL | 2025-09-08 | $5.2M | — | Filing → |